Bilirubin is a yellow-orange pigment produced when your body breaks down old red blood cells, and its levels in the blood serve as a surprisingly versatile window into how well your liver, blood, and bile system are functioning. A standard blood panel reports total bilirubin, with normal adult values generally falling between about 0.1 and 1.2 mg/dL. When levels climb above that range, the result is jaundice, the yellowing of skin and eyes that has been recognized as a sign of illness for thousands of years. But bilirubin is not simply a waste product to be cleared. Research over the past few decades has revealed that this pigment also acts as a potent antioxidant, and that mildly elevated levels may actually protect against heart disease and metabolic problems.
How Your Body Makes and Clears Bilirubin
Bilirubin begins its life inside macrophages, the immune cells that swallow and dismantle old or damaged red blood cells. When a red blood cell is broken down, its hemoglobin releases heme, a molecule built around an iron atom. An enzyme called heme oxygenase then cracks open the heme ring, producing biliverdin (a green pigment), carbon monoxide, and free iron. This step is actually the bottleneck of the entire process. Biliverdin is then quickly converted to bilirubin by a second enzyme, biliverdin reductase.1PMC. Bilirubin Hepatic and Intestinal Transport and Catabolism: Physiology, Pathophysiology, and Benefits – Section: 2.1. Heme Degradation Pathway
At this point, bilirubin is in its unconjugated form, meaning it has not yet been chemically modified for easy disposal. Unconjugated bilirubin is not water-soluble, so it hitches a ride through the bloodstream bound to the protein albumin. When it reaches the liver, hepatocytes take it up and hand it off to an internal carrier protein called ligandin. From there, an enzyme known as UGT1A1 attaches sugar molecules (glucuronic acid) to the bilirubin, converting it first to bilirubin monoglucuronide and then to bilirubin diglucuronide.2Gastroenterology. Hereditary Hyperbilirubinemias: Sources, Diagnostics, Treatment, and Health Effects – Section: Bilirubin Transport and Conjugation by the Liver This conjugation makes the pigment water-soluble so the liver can pump it into bile.
Once conjugated bilirubin enters the intestine via bile, gut bacteria strip off the sugar molecules and reduce it into a family of compounds called urobilinoids. Some of these are reabsorbed into the bloodstream and eventually excreted by the kidneys, giving urine its yellow color. The rest travel further down the intestine and are converted into stercobilin, the pigment responsible for the brown color of stool.3PubMed Central. Bilirubin in the Liver to Gut Signaling Axis – Section: Bilirubin excretion to the gut and microbiota catabolism If you have ever noticed very pale or clay-colored stools, that can be a sign that bilirubin is not reaching the intestine properly, often because of a bile duct blockage.
What Your Lab Results Actually Mean
When a doctor orders a bilirubin test, the lab typically reports three numbers: total bilirubin, direct (conjugated) bilirubin, and indirect (unconjugated) bilirubin. The indirect value is not measured on its own but calculated by subtracting direct from total. Distinguishing between the two forms is clinically useful because each points to a different set of problems.4Current Signal Transduction Therapy. An Evolution of Bilirubin Physiology and Analysis
Elevated unconjugated bilirubin suggests either that too much bilirubin is being produced (as happens when red blood cells are destroyed faster than normal, a condition called hemolysis) or that the liver is struggling to conjugate it. Elevated conjugated bilirubin, on the other hand, typically points to a problem with bile flow: the liver is conjugating bilirubin fine, but it cannot export it efficiently, often because of gallstones, tumors pressing on the bile duct, or liver diseases like hepatitis and cirrhosis. The most widely used lab method for measuring bilirubin relies on a coupling reaction with diazo dyes, a technique that has been refined since the early 20th century. More advanced methods, including enzyme-based assays and high-performance liquid chromatography, can distinguish the individual bilirubin species more precisely when needed.5PubMed. The analysis of bilirubin in serum
Why Newborns Get Jaundice So Often
Jaundice in the first week of life is so common that pediatricians treat it as a near-universal event rather than a rare diagnosis. Newborns produce bilirubin at roughly twice the rate of adults because their red blood cells have a shorter lifespan, and their immature livers have not yet ramped up production of UGT1A1. The result is so-called physiological jaundice, which typically appears between 24 and 72 hours after birth, peaks around day four or five in full-term babies (day seven in preterm infants), and resolves on its own within about two weeks. In otherwise healthy term newborns, bilirubin levels up to about 17 to 18 mg/dL may be considered within the normal physiological range.6PubMed Central. Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative Review Article – Section: Physiological Jaundice
Concern rises when levels push beyond that range or when jaundice appears within the first 24 hours of life, which usually signals something beyond normal immaturity, such as blood-type incompatibility between mother and baby. Unconjugated bilirubin at very high concentrations can cross from the blood into the brain. The blood-brain barrier normally restricts bilirubin entry, but in newborns this barrier is less mature. When albumin binding capacity is overwhelmed and free bilirubin accumulates, it can diffuse into brain tissue, causing a condition known as bilirubin-induced neurological dysfunction.7PubMed Central. Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models – Section: 2. Unravelling the Mechanisms Underlying BIND In the most severe cases, this can progress to kernicterus, a form of permanent brain damage. That risk is why hospitals monitor newborns closely.
Phototherapy and How It Works
The standard treatment for dangerously high newborn bilirubin is phototherapy, sometimes called “bili lights.” Babies are placed under blue-spectrum light, which penetrates the skin and converts bilirubin molecules into structural isomers that are water-soluble. These isomers can be excreted directly through bile and urine without needing to go through the normal conjugation step in the liver.8PubMed. Fundamentals of phototherapy for neonatal jaundice The discovery that sunlight helped jaundiced babies was actually serendipitous: nurses in a British hospital in the 1950s noticed that babies placed near windows improved faster. Today, the treatment is highly effective, and exchange transfusion, the older and riskier alternative, is rarely needed.
Screening for high bilirubin in newborns has also improved. Transcutaneous bilirubinometers, small handheld devices pressed against a baby’s forehead or chest, use light reflectance to estimate bilirubin levels without drawing blood. A large Cochrane review found that these devices are highly sensitive for ruling out significant jaundice: if the reading is low, you can be confident bilirubin is not dangerously elevated. But a high reading still needs to be confirmed with a blood draw.9PubMed Central. Transcutaneous bilirubinometry versus total serum bilirubin measurement for newborns Newer devices have shown high agreement with established instruments across a range of skin colors and gestational ages.10Scientific Reports. Evaluation of a new transcutaneous bilirubinometer in newborn infants
Gilbert’s Syndrome and Other Inherited Causes
If you are an adult who has been told your bilirubin is mildly high with no obvious explanation, Gilbert’s syndrome is the most likely cause. It affects somewhere around 5 to 10 percent of the general population, depending on how you define the cutoff. People with Gilbert’s syndrome have a genetic variant in the UGT1A1 gene, specifically a change in its promoter region (the TATA box) that reduces enzyme activity by roughly 30 percent. The result is a modest rise in unconjugated bilirubin, typically fluctuating between about 1 and 3 mg/dL. Total bilirubin levels in individuals with this syndrome are primarily determined by the specific TA duplication in the TATA-box promoter and by a related upstream variant.11PubMed. Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects Gilbert’s syndrome is considered benign. It requires no treatment, and most people discover it incidentally during routine blood work or when fasting, illness, or stress triggers a temporary spike.
At the more severe end of the spectrum sit the Crigler-Najjar syndromes, which involve much greater deficiency of UGT1A1. Crigler-Najjar type I results in near-total absence of the enzyme, leading to dangerously high unconjugated bilirubin from birth and a risk of kernicterus that persists into adulthood without aggressive treatment. Crigler-Najjar type II is milder, with residual enzyme activity. On the conjugated side, Dubin-Johnson syndrome is caused by mutations in the ABCC2 transporter, the pump that moves conjugated bilirubin out of liver cells into bile. People with this condition have mildly elevated conjugated bilirubin but, like Gilbert’s, the syndrome is generally benign.12Journal of Hepatology. Hyperbilirubinemia
The Cardiovascular Upside of Higher Bilirubin
Here is where bilirubin gets genuinely interesting. Multiple studies have found that people with mildly elevated bilirubin, including those with Gilbert’s syndrome, have a lower risk of heart disease. One of the earliest and most cited studies found that higher serum bilirubin was strongly and inversely related to coronary artery disease risk. After adjusting for other factors, each increase of about 1 mg/dL in bilirubin was associated with roughly 75 percent lower odds of early coronary artery disease.13PubMed. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease
Longitudinal data has reinforced this picture. A large study tracking participants over time found that those in the highest third of baseline bilirubin levels had a significantly lower risk of developing coronary heart disease and dying from cardiovascular causes compared to those in the lowest third.14PLOS ONE. Relationship between serum bilirubin levels and cardiovascular disease The proposed mechanism centers on bilirubin’s antioxidant properties. Unconjugated bilirubin is a potent scavenger of reactive oxygen species, and it cycles back and forth with biliverdin in a redox loop, meaning small amounts can neutralize far more oxidative damage than you might expect from their concentration alone. By reducing oxidation of LDL cholesterol, bilirubin may slow the formation of arterial plaques.
This does not mean you should try to raise your bilirubin levels artificially. The protective association is observational, and no clinical trials have tested whether deliberately increasing bilirubin prevents heart attacks. It does mean, though, that a mildly elevated bilirubin reading on a blood test is not automatically bad news, and in the absence of liver disease or hemolysis, it may actually reflect a metabolic advantage.
Bilirubin and Metabolic Protection
The antioxidant story extends beyond the heart. Animal research has shown that bilirubin plays a direct role in protecting the liver from fat accumulation and oxidative damage. Mice engineered to lack biliverdin reductase A, the enzyme that produces bilirubin, had negligible bilirubin in their plasma and liver. Despite having normal blood sugar control and insulin sensitivity, these mice developed inflamed, fatty livers. Their liver tissue accumulated oxidized fats and markers of oxidative stress, along with a depletion of vitamin E (alpha-tocopherol), another key antioxidant.15PubMed Central. Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance The finding is striking because it separates bilirubin’s protective role from the insulin resistance that typically accompanies fatty liver disease. It suggests bilirubin has a standalone shielding effect against oxidative liver damage, not merely a correlation with other healthy metabolic markers.
Things That Shift Your Bilirubin Without Disease
Before you worry about an unexpectedly high reading, it is worth knowing that several normal physiological factors can bump bilirubin up or down. Fasting is one of the most well-documented. A study of healthy volunteers in clinical trials found that fasting produced a statistically significant increase in total serum bilirubin in men, with longer fasting duration correlating with higher levels. Interestingly, this effect was not seen in women. Age did not play a role in the fasting response.16Journal of Clinical Pathology. Fasting increases serum bilirubin levels in clinically normal, healthy males but not females: a retrospective study from phase I clinical trial participants This sex difference is not fully explained, though hormonal influences on UGT1A1 expression are one hypothesis.
Other factors that can temporarily elevate bilirubin include strenuous exercise, high-altitude exposure, and certain medications. Dehydration can concentrate the blood and make bilirubin appear higher. If your doctor orders a bilirubin test, you will usually be asked to fast for a set number of hours beforehand, which standardizes the measurement but can paradoxically inflate the reading, especially in men. A repeat test under controlled conditions often resolves borderline results.
Bilirubin as a Drug Safety Signal
In pharmaceutical development, bilirubin plays a starring role in one of the most important safety rules in medicine: Hy’s Law, named after the late hepatologist Hyman Zimmerman. The principle states that when a drug causes liver-cell damage (shown by elevated liver enzymes) along with a rise in total bilirubin above twice the upper limit of normal, the risk of fatal liver failure jumps sharply. The reasoning is that the liver has an enormous reserve capacity, and if a drug manages to both injure liver cells and impair bilirubin clearance simultaneously, the damage is likely severe.
Data from the Drug-Induced Liver Injury Network has confirmed the prognostic value of this combination. Among patients meeting the hepatocellular injury pattern with elevated bilirubin, fatality rates were roughly 10 to 11 percent, compared with about 1.5 to 2 percent in those with a cholestatic or mixed pattern.17PubMed Central. Refinement of Hy’s Law using the Drug-Induced Liver Injury Network Database Hy’s Law criteria have high specificity for predicting acute liver failure, meaning that when the criteria are not met, serious liver failure is very unlikely. However, sensitivity is moderate, so meeting the criteria does not guarantee a bad outcome.18PubMed Central. Risk of Acute Liver Failure in Patients with Drug-Induced Liver Injury: Evaluation of Hy’s Law and a New Prognostic Model Drug regulators like the FDA treat even a single Hy’s Law case during a clinical trial as a serious red flag. Recent work on refining the formula suggests that updated criteria using a different liver enzyme ratio may be more sensitive at catching the most severe outcomes.19PubMed. R Value-Based Criteria Outperform Alkaline Phosphatase Less than Twice Normal in Identifying Hy’s Law Cases in Clinical Trials
Why Bilirubin Instead of Biliverdin
From a biochemistry standpoint, converting biliverdin to bilirubin seems wasteful. Biliverdin is already water-soluble and could be excreted directly. The extra enzymatic step to make bilirubin, which then needs to be conjugated back into a water-soluble form, costs the body energy. So why do humans and many other animals bother?
One compelling hypothesis involves gut protection. Free (unconjugated) bilirubin in the intestine significantly inhibits trypsin and chymotrypsin, two major digestive proteases. At a concentration of 10 micromoles per liter, bilirubin inhibited about 61 percent of the proteolytic activation of chymotrypsinogen. Conjugated bilirubin and biliverdin did not share this effect.20PubMed Central. Inactivation of digestive proteases by deconjugated bilirubin: the possible evolutionary driving force for bilirubin or biliverdin predominance in animals The researchers noted a telling pattern across the animal kingdom: carnivores and omnivores, whose diets demand heavy protease activity, tend to have bilirubin-rich bile, while herbivores like rabbits, sloths, and plant-eating birds tend to have biliverdin-dominant bile instead. The theory is that bilirubin acts as a brake on digestive enzymes in the gut, preventing them from damaging the intestinal lining, and this advantage is more critical for animals eating high-protein diets.
How Jaundice Got Its Name
The word “icterus,” still used in medicine as a synonym for jaundice, traces back to ancient Greek. The term ikteros referred both to the yellow discoloration of a sick person and to the Eurasian golden oriole, a strikingly yellow bird. Ancient healers believed that gazing upon the bird could cure jaundice, a treatment-by-sympathy that predated any understanding of bile chemistry by millennia. The pigment itself was not chemically isolated until the 19th century. In 1863, the chemist Georg Städeler gave it the name bilirubin, from the Latin words for bile (bilis) and red (ruber), reflecting the reddish-yellow crystals he observed.21PubMed Central. A historical review of jaundice: May the golden oriole live forever – Section: THE EURASIAN GOLDEN ORIOLE The development of a practical blood test came decades later, when the Dutch physician Abraham Hijmans van den Bergh created a colorimetric assay for serum bilirubin, the ancestor of the diazo-based tests still used in labs today. His “van den Bergh reaction” was also the origin of the direct and indirect bilirubin distinction, which he discovered somewhat accidentally when he noticed that some patients’ serum reacted immediately with his reagent while others required the addition of alcohol.